Evidence map›Paper›PMID 30238078›Full record

ArticleAnnals of gastroenterological surgery2018

Preoperative globulin-to-albumin ratio predicts outcome after curative resection in patients with gastric cancer.

Takayuki Shimizu, Mitsuru Ishizuka, Norisuke Shibuya, Genki Tanaka, Akihito Abe, Taku Aoki, Keiichi Kubota

Abstract read
In one paragraph

Article in Annals of gastroenterological surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Takayuki ShimizuSecond Department of Surgery Dokkyo Medical University Tochigi Japan.ORCID 0000-0002-2727-842X
Mitsuru IshizukaSecond Department of Surgery Dokkyo Medical University Tochigi Japan.ORCID 0000-0003-3241-1480
Norisuke ShibuyaSecond Department of Surgery Dokkyo Medical University Tochigi Japan.ORCID 0000-0003-1367-295X
Genki TanakaSecond Department of Surgery Dokkyo Medical University Tochigi Japan.
Akihito AbeSecond Department of Surgery Dokkyo Medical University Tochigi Japan.
Taku AokiSecond Department of Surgery Dokkyo Medical University Tochigi Japan.
Keiichi KubotaSecond Department of Surgery Dokkyo Medical University Tochigi Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe globulin-to-albumin ratio (GAR) is useful for prognostication of patients with various cancers. However, the significance of GAR in gastric cancer (GC) remains unclear. Our purpose was to investigate the relationship between the GAR and outcome after curative resection in GC patients.

methodsThree-hundred and seventy-six patients who had undergone curative resection for GC were retrospectively reviewed. Univariate and multivariate analyses using the Cox proportional hazard model were performed to detect clinical characteristics that correlated with overall survival (OS), and their cut-off values were identified using receiver operating characteristic (ROC) curve analyses. Kaplan-Meier analysis and log-rank test were used for comparison of OS and relapse-free survival (RFS).

resultsMultivariate analysis using 17 clinical characteristics selected by univariate analyses revealed that GAR (>0.80/≤0.80) was significantly associated with OS (hazard ratio [HR], 2.305; 95% CI, 1.122-4.735;

conclusionsThe GAR is a useful predictor of postoperative outcome among GC patients undergoing curative resection.

Indexed as

curative resectiongastric cancerglobulin‐to‐albumin ratioinflammation‐based prognostic systempostoperative survival

Identifiers

PMID30238078
PMCPMC6139717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.